Detailed answers about MERIDAX CLINICAL SOLUTIONS LTD, including incorporation, status, business activity, and accounts information.
When was MERIDAX CLINICAL SOLUTIONS LTD founded?
MERIDAX CLINICAL SOLUTIONS LTD was officially incorporated on 9 July 2026 and is registered under company number 17330031. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is MERIDAX CLINICAL SOLUTIONS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of MERIDAX CLINICAL SOLUTIONS LTD?
MERIDAX CLINICAL SOLUTIONS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does MERIDAX CLINICAL SOLUTIONS LTD do?
MERIDAX CLINICAL SOLUTIONS LTD operates in the following sectors: 70229 - Management consultancy activities other than financial management, 72190 - Other research and experimental development on natural sciences and engineering, 74909 - Other professional, scientific and technical activities n.e.c., 85590 - Other education n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is MERIDAX CLINICAL SOLUTIONS LTD's registered address?
The registered office address of MERIDAX CLINICAL SOLUTIONS LTD is 66 Paul Street, London, England, EC2A 4NA. This is the official address filed with Companies House for legal and statutory correspondence.
Is MERIDAX CLINICAL SOLUTIONS LTD financially stable?
Financial accounts for MERIDAX CLINICAL SOLUTIONS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.